Skip to Content
Merck
  • Carbonyl Posttranslational Modification Associated With Early-Onset Type 1 Diabetes Autoimmunity.

Carbonyl Posttranslational Modification Associated With Early-Onset Type 1 Diabetes Autoimmunity.

Diabetes (2022-06-23)
Mei-Ling Yang, Sean E Connolly, Renelle J Gee, TuKiet T Lam, Jean Kanyo, Jian Peng, Perrin Guyer, Farooq Syed, Hubert M Tse, Steven G Clarke, Catherine F Clarke, Eddie A James, Cate Speake, Carmella Evans-Molina, Peter Arvan, Kevan C Herold, Li Wen, Mark J Mamula
ABSTRACT

Inflammation and oxidative stress in pancreatic islets amplify the appearance of various posttranslational modifications to self-proteins. In this study, we identified a select group of carbonylated islet proteins arising before the onset of hyperglycemia in NOD mice. Of interest, we identified carbonyl modification of the prolyl-4-hydroxylase β subunit (P4Hb) that is responsible for proinsulin folding and trafficking as an autoantigen in both human and murine type 1 diabetes. We found that carbonylated P4Hb is amplified in stressed islets coincident with decreased glucose-stimulated insulin secretion and altered proinsulin-to-insulin ratios. Autoantibodies against P4Hb were detected in prediabetic NOD mice and in early human type 1 diabetes prior to the onset of anti-insulin autoimmunity. Moreover, we identify autoreactive CD4+ T-cell responses toward carbonyl-P4Hb epitopes in the circulation of patients with type 1 diabetes. Our studies provide mechanistic insight into the pathways of proinsulin metabolism and in creating autoantigenic forms of insulin in type 1 diabetes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-DNP antibody produced in goat, whole antiserum